Merck & Co.'s Solid Growth Turbo-Charged By Lagevrio For COVID-19
Even without Lagevrio, Merck's base business grew by double digits; the company raised its revenue guidance for the year.
Even without Lagevrio, Merck's base business grew by double digits; the company raised its revenue guidance for the year.